As part of the QuintilesIMS premiere network of high performing , high quality research sites, Renstar Medical Research was awarded a Certificate of Achievement, recognizing our commitment to the highest standards of clinical research on projects with QuintilesIMS in 2016. Our relationship with QuintilesIMS promotes collaboration to support awareness of, and access to, clinical research trials for the patients we serve. Together, we are changing the way clinical trials are executed, to help ensure lifesaving treatments are available sooner to patients around the globe.
Quintiles IMS is the world’s largest contract research organization (CRO) and the largest provider of biopharmaceutical development with expertise in health information technologies and clinical research. Their primary focus is on Phase II-IV clinical trials with a separate concentration on laboratory and analytical services.